Bergeson, LLP will continue its operations during the disruption caused by COVID-19. Our attorneys and staff are well-equipped to operate remotely and will be doing so consistent with recent guidance from local authorities until further notice.

The health and safety of our employees, clients, and the community is paramount. We are committed to remaining fully accessible to our clients during this difficult time. Please do not hesitate to contact us if you have any questions or concerns. We wish you good health.

Life Sciences Litigation

Bergeson, LLP regularly represents clients in the biotech and medical device sectors.  Bergeson, LLP’s lawyers have litigated on behalf of clients engaged in developing a variety of technologies aimed at addressing real-world health issues, in matters against competitors, partners and other entities.

A sampling of our representative matters involving clients in the life sciences arena includes:

Representation of a company and university researchers developing technology to assist in determining human embryos’ potential for developmental competence in a declaratory judgment patent action.

Representation of a company developing products to address bowel incontinence in a case involving declaratory relief and breach of contract claims relating to IP ownership, confidential information and solicitation.

Representation of a company engaged in the development of intraocular accommodating lenses for the treatment of cataracts and other serious eye conditions in an action for trade secret misappropriation, breach of contract, misrepresentation and other claims.

Representation of a company that provided services related to computer-assisted surgery and endoscopies in a patent infringement lawsuit.